ニューヨークにおける消化器がんの臨床試験
ニューヨーク内の拠点で、消化器がんに関する14件の研究が参加者を募集しています。
ニューヨーク内の都市
公式研究テキスト（英語）
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Montefiore Medical Center-Einstein Campus, The Bronx
- James J Peters VA Medical Center, The Bronx
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07283939Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- NYOH Albany Cancer Center, Albany
- Hematology-Oncology Associates of Central New York, PC, Auburn
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon
- 他12件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07222800A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
- GSK Investigational Site, New Hyde Park
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07218926Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Columbia University, New York
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06128551Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Northwell Health / RJ Zuckerberg Cancer Center, Lake Success
- Columbia University Medical Center, New York
- Memorial Sloan Kettering Cancer Center Main Campus, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06445062Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
- Roswell Park Comprehensive Cancer Center, Buffalo
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/21更新 · NCT05274048A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
- Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- 他1件
被験者募集中
18歳以上 · 全性別 · 2026/09/02更新 · NCT05837767Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- New York Cancer & Blood Specialists, New York
- University of Rochester - Wilmot Cancer Institute, Rochester
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/27更新 · NCT06582017A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- 他1件
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/25更新 · NCT05789485A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
- GSK Investigational Site, New York
- GSK Investigational Site, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/03更新 · NCT06885034Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- NYU Langone, New York
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/03更新 · NCT06040541Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Perlmutter Cancer Center at NYU Langone Health, New York
- Memorial Sloan-Kettering Cancer Center, New York
- Columbia University, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/15更新 · NCT05379985A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Laura & Isaac Perlmutter Cancer Center at NYU Langone, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/22更新 · NCT07020221Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
- The New York Proton Center, New York
被験者募集中
18歳以上 · 全性別 · 2026/04/13更新 · NCT05313191ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。